Correction to: Talin1 promotes HCC progression by regulating NRG1/PI3K/AKT pathway

Correction: Discover Oncology (2024) 15:360

10.1007/s12672-024-01243-2

The original publication of this article contained several errors, which included improper description, misspelling of words, shifting of the ROI (Region of Interest) indicator box of two microscopic images, and a repeated upload of statistical chart.

The incorrect and correct information is shown in this correction article, the original article has been updated. This does not impact the results nor conclusions of the study.

Figure 1C legend

Incorrect

n = 100 in each group, scale bar = 100 mµ.

Correct

Low expression group, n = 23; high expression group, n = 77.” scale bar = 100 μm.

Figure 1D legend

Incorrect

n = 100 in each group.

Correct

Low expression group, n = 23; high expression group, n = 77.

Figure 1E

Incorrect Y axis

Recurrence rates

Correct Y axis

Recurrence free rates

Figure 6A

In the WB assay of Huh-7 cells on the left side, the names of Talin1 protein on the upper side and GAPDH protein on the lower side were forgotten to be labeled due to our carelessness.

Incorrect Fig. 6a

Correct Fig. 6a

Material and methods Sect. 2.6 Immunohistochemical staining assay

Incorrect

0 (+), 1 (++), 2 (+++), and 3 (++++).

Correct

0 (−), 1 (+), 2 (++), and 3 (+++).

Figure 1 A

Incorrect Y axis

Talim1 expression

Correct Y axis

Talin1 expression

Figure 5A. Legend

Incorrect

NGR-1 upregulation in cells

Correct

NRG-1 upregulation in cells

4th paragraph of 4. Discussion section

Incorrect

… we demonstrated that Tian1.

Correct

… we demonstrated that Tiam1.

Placement ROI indicator box Fig. 1c

Incorrect

Correct

Placement ROI indicator box Fig. 3a

Incorrect

Correct

Statistical chart Fig. 6c

Incorrect

Correct